Login
$JAGX
$2.37 +$0.33 (16.18%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash
Restricted cash
Accounts receivable, net
Other receivable
Inventory, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease - right-of-use asset
Intangible assets, net
Other assets
Total assets
Liabilities and Stockholders' Equity (Deficit)
Current liabilities:
Accounts payable
Accrued liabilities
Deferred revenue
Operating lease liability, current
Notes payable, net of discount (includes note designated at Fair Value Option amounting to $8.3 million as of June 30, 2026, and $26.2 million as of December 31, 2025, respectively)
Series O convertible preferred stock: $0.0001 par value; 1,557,000 and 0 shares authorized at June 30, 2026 and December 31, 2025, respectively; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025
Series J Redeemable Preferred Stock
Series O Convertible Preferred Stock
Total series O convertible preferred stock: $0.0001 par value; 1,557,000 and 0 shares authorized at June 30, 2026 and December 31, 2025, respectively; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025
Total current liabilities
Operating lease liability, net of current portion
Deferred revenue, net of current portion
Derivative liability
Commitment share liability
Notes payable, net of discount, net of current portion (includes notes designated at Fair Value Option amounting to $0 as of June 30, 2026, and $5.7 million as of December 31, 2025, respectively)
Total liabilities
Stockholders' equity (deficit)
Preferred stock value
Common stock value
Common stock - voting
Common stock - non-voting
Additional paid-in capital
Noncontrolling interest
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity (deficit)
Total liabilities and stockholders' equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support